Skip to main content

Advertisement

SpringerLink
Log in

A case of primary (AL) amyloidosis with predominantly vascular amyloid deposition in the kidney

  • Case Report
  • Published:
CEN Case Reports Aims and scope Submit manuscript

Abstract

We report a 70-year-old man with primary (AL) amyloidosis with predominantly vascular deposition of amyloid diagnosed by renal biopsy, who was successfully treated using two chemotherapy regimens. There was rapid elevation of the serum creatinine level without remarkable proteinuria or hematuria. Renal histological examination showed some thickened arterial walls with amyloid fibril accumulation, and only a small amount of amyloid deposition in the glomeruli. Immunohistochemical examination was positive for anti-kappa staining. Serum immunoelectrophoresis and immunofixation testing did not show monoclonal proteins, and urine immunoelectrophoresis did not show Bence-Jones proteins. Serum free light chain (FLC) analysis showed that the serum FLC level and FLC kappa/lambda ratio were abnormally high for his renal function. He received two courses of VAD (vincristine, doxorubicin, and dexamethasone), followed by BD (bortezomib and dexamethasone), resulting in a hematologic partial response. Renal amyloidosis with vascular-limited amyloid deposition has few urinary findings. Early diagnosis of this condition is challenging, because kidney biopsies are not usually performed in patients without significant urinary findings. We suggest several currently available methods of achieving earlier detection of this condition.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

References

  1. Sipe JD, Benson MD, Buxbaum JN, et al. Amyloid fibril protein nomenclature: 2012 recommendations from the Nomenclature Committee of the International Society of Amyloidosis. Amyloid. 2012;19:167–70.

    Article  CAS  PubMed  Google Scholar 

  2. Eirin A, Irazabal MV, Gertz MA, et al. Clinical features of patients with immunoglobulin light chain amyloidosis (AL) with vascular-limited deposition in the kidney. Nephrol Dial Transplant. 2012;27:1097–101.

    Article  CAS  PubMed  Google Scholar 

  3. Falck HM, Törnroth T, Wegelius O. Predominantly vascular amyloid deposition in the kidney in patients with minimal or no proteinuria. Clin Nephrol. 1983;19:137–42.

    CAS  PubMed  Google Scholar 

  4. Reece DE, Hegenbart U, Sanchorawala V, et al. Efficacy and safety of once-weekly and twice-weekly bortezomib in patients with relapsed systemic AL amyloidosis: results of a phase 1/2 study. Blood. 2011;118:865–73.

    Article  CAS  PubMed  Google Scholar 

  5. Reece DE, Sanchorawala V, Hegenbart U, VELCADE CAN2007 Study Group, et al. Weekly and twice-weekly bortezomib in patients with systemic AL amyloidosis: results of a phase 1 dose-escalation study. Blood. 2009;114:1489–97.

    Article  CAS  PubMed  Google Scholar 

  6. Kastritis E, Wechalekar AD, Dimopoulos MA, et al. Bortezomib with or without dexamethasone in primary systemic (light chain) amyloidosis. J Clin Oncol. 2010;28:1031–7.

    Article  CAS  PubMed  Google Scholar 

  7. Dember LM. Amyloidosis-associated kidney disease. J Am Soc Nephrol. 2006;12:3458–71.

    Article  Google Scholar 

  8. Uda H, Yokota A, Kobayashi K, et al. Two distinct clinical courses of renal involvement in rheumatoid patients with AA amyloidosis. J Rheumatol. 2006;33:1482–7.

    PubMed  Google Scholar 

  9. Yao Y, Wang SX, Zhang YK, et al. A clinicopathological analysis in a large cohort of Chinese patients with renal amyloid light-chain amyloidosis. Nephrol Dial Transplant. 2013;28:689–97.

    Article  CAS  PubMed  Google Scholar 

  10. Katzmann JA, Abraham RS, Dispenzieri A, et al. Diagnostic performance of quantitative kappa and lambda free light chain assays in clinical practice. Clin Chem. 2005;51:878–81.

    Article  CAS  PubMed  Google Scholar 

  11. Bochtler T, Hegenbart U, Heiss C, et al. Evaluation of the serum-free light chain test in untreated patients with AL amyloidosis. Haematologica. 2008;93:459–62.

    Article  CAS  PubMed  Google Scholar 

  12. Hutchison CA, Harding S, Hewins P, et al. Quantitative assessment of serum and urinary polyclonal free light chains in patients with chronic kidney disease. Clin J Am Soc Nephrol. 2008;3:1684–90.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  13. Gertz MA, Comenzo R, Falk RH, et al. Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18–22 April 2004. Am J Hematol. 2005;79:319–28.

    Article  PubMed  Google Scholar 

  14. Lachmann HJ, Gallimore R, Gillmore JD, et al. Outcome in systemic AL amyloidosis in relation to changes in concentration of circulating free immunoglobulin light chains following chemotherapy. Br J Haematol. 2003;122:78–84.

    Article  CAS  PubMed  Google Scholar 

  15. Duston MA, Skinner M, Meenan RF, et al. Sensitivity, specificity, and predictive value of abdominal fat aspiration for the diagnosis of amyloidosis. Arthritis Rheum. 1989;32:82–5.

    Article  CAS  PubMed  Google Scholar 

  16. Westermark P, Davey E, Lindbom K, et al. Subcutaneous fat tissue for diagnosis and studies of systemic amyloidosis. Acta Histochem. 2006;108:209–13.

    Article  PubMed  Google Scholar 

  17. van Gameren II, Hazenberg BP, Bijzet J, et al. Diagnostic accuracy of subcutaneous abdominal fat tissue aspiration for detecting systemic amyloidosis and its utility in clinical practice. Arthritis Rheum. 2006;54:2015–21.

    Article  PubMed  Google Scholar 

  18. Dhingra S, Krishnani N, Kumari N, et al. Evaluation of abdominal fat pad aspiration cytology and grading for detection in systemic amyloidosis. Acta Cytol. 2007;51:860–4.

    Article  PubMed  Google Scholar 

  19. Duston MA, Skinner M, Shirahama T, et al. Diagnosis of amyloidosis by abdominal fat aspiration: analysis of four years’ experience. Am J Med. 1987;82:412–4.

    Article  CAS  PubMed  Google Scholar 

  20. Sungur C, Sungur A, Ruacan S, et al. Diagnostic value of bone marrow biopsy in patients with renal disease secondary to familial Mediterranean fever. Kidney Int. 1993;44:834–6.

    Article  CAS  PubMed  Google Scholar 

  21. Kyle RA, Linos A, Beard CM, et al. Incidence and natural history of primary systemic amyloidosis in Olmsted County, Minnesota, 1950 through 1989. Blood. 1992;79:1817–22.

    CAS  PubMed  Google Scholar 

  22. O’Neill WC. Sonographic evaluation of renal failure. Am J Kidney Dis. 2000;35:1021–38.

    Article  PubMed  Google Scholar 

  23. Neaton JD, Kuller LH, Wentworth D, et al. Total and cardiovascular mortality in relation to cigarette smoking, serum cholesterol concentration, and diastolic blood pressure among black and white males followed up for five years. Am Heart J. 1984;108:759–69.

    Article  CAS  PubMed  Google Scholar 

  24. Freedman BI, Iskandar SS, Appel RG. The link between hypertension and nephrosclerosis. Am J Kidney Dis. 1995;25:207–21.

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

The authors have declared that no conflict of interest exists.

Author information

Authors and Affiliations

  1. Department of Nephrology, Seirei Mikatahara General Hospital, 3453 Mitakahara-cho, Kita-ku, Hamamatsu, Shizuoka, 433-8558, Japan

    Yoichi Murakami, Soken Hattori, Fumiko Sugiyama, Kazuyuki Yoshikawa, Takeshi Sugiura & Hideki Matsushima

Authors
  1. Yoichi Murakami
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Soken Hattori
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Fumiko Sugiyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kazuyuki Yoshikawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Takeshi Sugiura
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Hideki Matsushima
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yoichi Murakami.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Murakami, Y., Hattori, S., Sugiyama, F. et al. A case of primary (AL) amyloidosis with predominantly vascular amyloid deposition in the kidney. CEN Case Rep 4, 151–156 (2015). https://doi.org/10.1007/s13730-014-0157-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13730-014-0157-7

Keywords

Search

Navigation